Tembara is an independent information resource. If you have corrections, questions, or feedback about our site and its presentation, we welcome succinct notes that help improve accuracy and clarity.
At present the site does not publish a direct email or form. The site can be reached through its published channels; please check back for contact details or consult the editorial overview for how we handle corrections and sourcing.
For detail on editorial principles, sources, and how content is chosen, see our editorial summary on the about page which explains the site's mission and approach.
Tembara is an independent resource on ibogaine, its investigational uses, and its significant risks. It helps people interpret evidence, regulation, and safety concerns without overstating benefits.
Because this page concerns contact information only, it intentionally provides only site-channel guidance. For context about coverage and sourcing, the about page describes editorial standards and how we manage corrections.